Targeted lung denervation for moderate to severe COPD: A pilot study

Thorax

Volumn 70, Issue 5, 2015, Pages 411-419

  Slebos, Dirk Jan ^a   Klooster, Karin ^a   Koegelenberg, Coenraad F N ^b   Theron, Johan ^c   Styen, Dorothy ^b   Valipour, Arschang ^d   Mayse, Martin ^e   Bolliger, Chris T ^b,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Biomedical Sciences   (South Africa)

^c Panorama Medi Clinic   (South Africa)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^e Holaira Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; LONG ACTING DRUG; SHORT ACTING DRUG; TIOTROPIUM BROMIDE;

ABSCESS; ADOLESCENT; ADULT; ANAPHYLAXIS; ARTICLE; BACKACHE; BRONCHITIS; BRONCHOSCOPY; BRONCHUS PERFORATION; BRONCHUS STENOSIS; CANDIDIASIS; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMMON COLD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COUGHING; DENERVATION; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; DYSPNEA; ECZEMA; ENDURANCE; EXERCISE; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTRITIS; GRANULOMA; HEADACHE; HUMAN; INFLUENZA; LUNG FUNCTION; LUNG INFECTION; MALE; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; PARASYMPATHETIC INNERVATION; PARASYMPATHETIC NERVE; PILOT STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SINUSITIS; SMOOTH MUSCLE; SORE THROAT; ST. GEORGE RESPIRATORY QUESTIONNAIRE; STOMACH CANCER; STOMACH PARESIS; TARGETED LUNG DENERVATION; THORAX PAIN; TOOTH DISEASE; TRACHEA INJURY; AGED; CATHETER ABLATION; CLINICAL TRIAL; COHORT ANALYSIS; DEVICES; EXERCISE TOLERANCE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; VAGOTOMY;

AGED; BRONCHOSCOPY; CATHETER ABLATION; COHORT STUDIES; EXERCISE TOLERANCE; FEASIBILITY STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PARASYMPATHECTOMY; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TOTAL LUNG CAPACITY; TREATMENT OUTCOME;

EID: 84929470692     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-206146     Document Type: Article

References (26)

1. Canning B. Reflex regulation of airway smooth muscle tone. J Appl Physiol 2006;101:971-85.
2. Belmonte K. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. ProcAm Thor Soc 2005;2:297-305.
3. Pera T, Zuidhof A, Valadas J, et al. Tiotropium inhibits pulmonary inflammation and remodeling in a guinea pig model of COPD. Eur Respir J 2011;38:789-96.
4. Klassen KD, Morton DR. The effect of vagus section on the cough reflex, bronchial caliber, and clearance of bronchial secretions. Surgery 1951;29:483-90.
5. Jammes Y, Mei N. Assessment of the pulmonary origin of bronchoconstrictor vagal tone. J Physiol 1979;291:305-16.
6. Abbott OA, Hopkins WA, Van Fleit WE, et al. A new approach to pulmonary emphysema. Thorax 1953;8:116-31.
7. Dimitrov-Szokodi D, Husveti A, Balogh G. Lung Denervation in the Therapy of ntractable Bronchial Asthma. J Thoracic Surg 1957;33:166-84.
8. Gosens R, Zaagsma J, Meurs H, et al. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 2006;7:73.
9. Vincken W, van Noord JA, Greefhorst APM. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002;19:209-16.
10. Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008;31:742-50.
11. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chonic obstructive pulmonary disease. NEJM 2008;359:1543-54.
12. Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005;128;1168-78.
13. Global Strategy for the Diagnosis, Management and Prevention of COPD. 2014. [http://www.goldcopd.org]
14. Qaseem A, Wilt T, Weinberger S, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice Guideline update from the ACP, ACCP, ATS and ERS. Ann intern Med 2011;155:179-91.
15. Meguro M, Barley E, Spencer S, et al. Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. CHEST 2007;132:456-63.
16. Van der Molen T, Willemse B, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13.
17. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6.
18. Maltais F, Hamilton A, Marciniuk D, et al. Improvement in Symptom-Limited Exercise Performance over 8 h With Once-Daily Tiotropium in Patients with COPD. Chest 2005;128:1168-78.
19. Miller M, Hankinson J, Brusasco V, et al. Series "ATS/ERS Task Force: Standardization of Lung Function Testing". Eur Respir J 2005;26:319-38.
20. Wagner J, Clausen J, Coates A, et al. Series "ATS/ERS Task Force: Standardization of Lung Function Testing". Eur Respir J 2005;26:511-22.
21. Weisman IM, Beck KC, Casaburi R, et al. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:211-77.
22. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
23. Breekveldt-Postma NS, Koerselmana J, Erkensa JA, et al. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med 2007;101:1398-405.
24. Maesen FPV, Smeets JJ, Sledsens TJH, et al. Iprotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8:1506-13.
25. Anderson P. Use of Respimat Soft Mist Inhaler in COPD patients. Int J Chron Obstruct Pulmon Dis 2006;1:251-9.
26. Profita M, Albano GD, Riccobono L, et al. Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patients. Immunobiology 2014;219:392-401.